Over 150 Nordic companies applied to the launch of the first-ever Nordic Life Science Investment Day, NLS Invest. Following a long review of the applications by a pan-Nordic committee of industry leaders, 80 Rising Stars were ultimately selected to pitch to investors across three dedicated tracks: biotech/pharma, medtech/diagnostics and digital/e-health.

From the 80 Rising Stars, one company from each track was selected as the category winner, and RESPINOR was announced winner of the Medtech/Diagnostics tracks. See the full press release in the link below:

https://press.swedenbio.se/posts/pressreleases/apoglyx-respinor-and-retinarisk-announced-as

‍